These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21968664

  • 1. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
    Parish LC, Parish JL, Routh HB, Avakian E, Olayinka B, Pappert EJ, Plaum S, Fleischer AB, Hardas B.
    J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
    Parish LC, Parish JL, Routh HB, Fleischer AB, Avakian EV, Plaum S, Hardas B.
    J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB, Verma A, Olayinka B, Hardas B.
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
    Gold M, Dhawan S, Verma A, Kuligowski M, Dobrowski D.
    J Drugs Dermatol; 2016 Jun 01; 15(6):743-8. PubMed ID: 27272083
    [Abstract] [Full Text] [Related]

  • 5. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Oct 01; 14(10):1138-44. PubMed ID: 26461826
    [Abstract] [Full Text] [Related]

  • 6. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U, Bramono K, Urip KS, Basuki S, Widodo G, Rapatz G, Paul C.
    Mycoses; 2001 Oct 01; 44(7-8):300-6. PubMed ID: 11714065
    [Abstract] [Full Text] [Related]

  • 7. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
    Gold MH, Bridges T, Avakian E, Plaum S, Pappert EJ, Fleischer AB, Hardas B.
    Skinmed; 2011 Oct 01; 9(5):283-6. PubMed ID: 22165042
    [Abstract] [Full Text] [Related]

  • 8. Topical antifungal treatments for tinea cruris and tinea corporis.
    El-Gohary M, van Zuuren EJ, Fedorowicz Z, Burgess H, Doney L, Stuart B, Moore M, Little P.
    Cochrane Database Syst Rev; 2014 Aug 04; 2014(8):CD009992. PubMed ID: 25090020
    [Abstract] [Full Text] [Related]

  • 9. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
    Jones TM, Jarratt MT, Mendez-Moguel I, Paz N, Grekin SK, Cognata Smith C, Kaur M.
    J Drugs Dermatol; 2014 Jan 04; 13(1):32-8. PubMed ID: 24385117
    [Abstract] [Full Text] [Related]

  • 10. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
    Cutis; 1991 Jul 04; 48(1):85-8. PubMed ID: 1868748
    [Abstract] [Full Text] [Related]

  • 11. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis.
    Jordon RE, Rapini RP, Rex IH, Katz HI, Hickman JG, Bard JW, Medansky RS, Lew-Kaya DA, Sefton J, DeGryse RE.
    Int J Dermatol; 1990 Jul 04; 29(6):441-2. PubMed ID: 2397973
    [Abstract] [Full Text] [Related]

  • 12. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis.
    Millikan LE, Galen WK, Gewirtzman GB, Horwitz SN, Landow RK, Nesbitt LT, Roth HL, Sefton J, Day RM.
    J Am Acad Dermatol; 1988 Jan 04; 18(1 Pt 1):52-6. PubMed ID: 3279083
    [Abstract] [Full Text] [Related]

  • 13. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A, Saúl A.
    Eur J Dermatol; 2000 Mar 04; 10(2):107-9. PubMed ID: 10694308
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Jul 04; 14(7):686-91. PubMed ID: 26151784
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P, Houpt KR, LaMarca A, Loven KH, Marbury TC, Matheson R, Miller B, Smith S, Wolf J, Tinea Corporis/Tinea Cruris Research Group.
    Cutis; 2001 Jul 04; 68(1 Suppl):15-22. PubMed ID: 11499330
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A, Pandhi D, Agrawal S, Das S.
    J Dermatolog Treat; 2005 Jul 04; 16(5-6):331-5. PubMed ID: 16428155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.